APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain-relieving API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pain-relieving API Market Outlook and Growth Opportunities 2026

31 December 2025194 pages

Choose your research edition.

Industry ResearchPain-relieving API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain-relieving API Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pain-relieving API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain-relieving API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain-relieving API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pain-relieving API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pain-relieving API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pain-relieving API market include Xinhua Pharmaceutical, Sanofi, Biocause Heilen, SOLARA, SI Group, Noramco, IOLCP, Biocause and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pain-relieving API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain-relieving API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain-relieving API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain-relieving API market size, projected growth trends, production technologies, key applications, and end-use industries.

Pain-relieving API Segment by Company

Xinhua Pharmaceutical

Sanofi

Biocause Heilen

SOLARA

SI Group

Noramco

IOLCP

Biocause

BASF

Aspen API The Netherlands

Pain-relieving API Segment by Type

Opiate

Non-Opiate

Pain-relieving API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Pain-relieving API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pain-relieving API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pain-relieving API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pain-relieving API significant trends, drivers, influence factors in global and regions.

6. To analyze Pain-relieving API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain-relieving API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain-relieving API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain-relieving API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pain-relieving API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain-relieving API industry.

Chapter 3: Detailed analysis of Pain-relieving API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pain-relieving API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pain-relieving API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pain-relieving API Industry Trends Table 2. Pain-relieving API Industry Drivers Table 3. Pain-relieving API Industry Opportunities and Challenges Table 4. Pain-relieving API Industry Restraints Table 5. Global Pain-relieving API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pain-relieving API Revenue Share by Company (2021-2026) Table 7. Global Pain-relieving API Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pain-relieving API Sales Volume Share by Company (2021-2026) Table 9. Global Pain-relieving API Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pain-relieving API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pain-relieving API Key Company Manufacturing Base & Headquarters Table 12. Global Pain-relieving API Company, Product Type & Application Table 13. Global Pain-relieving API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pain-relieving API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Opiate Table 18. Significant Companies of Non-Opiate Table 19. Global Pain-relieving API Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pain-relieving API Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Pain-relieving API Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Pain-relieving API Sales Volume Share by Type (2021-2026) Table 23. Global Pain-relieving API Sales Volume Share by Type (2027-2032) Table 24. Global Pain-relieving API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pain-relieving API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pain-relieving API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pain-relieving API Sales Value Share by Type (2021-2026) Table 28. Global Pain-relieving API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Contract Manufacturing Organizations Table 30. Significant Companies of Pharmaceutical Companies Table 31. Significant Companies of Others Table 32. Global Pain-relieving API Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pain-relieving API Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Pain-relieving API Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Pain-relieving API Sales Volume Share by Application (2021-2026) Table 36. Global Pain-relieving API Sales Volume Share by Application (2027-2032) Table 37. Global Pain-relieving API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pain-relieving API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pain-relieving API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pain-relieving API Sales Value Share by Application (2021-2026) Table 41. Global Pain-relieving API Sales Value Share by Application (2027-2032) Table 42. Global Pain-relieving API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pain-relieving API Sales by Region (2021-2026) & (K Units) Table 44. Global Pain-relieving API Sales Market Share by Region (2021-2026) Table 45. Global Pain-relieving API Sales by Region (2027-2032) & (K Units) Table 46. Global Pain-relieving API Sales Market Share by Region (2027-2032) Table 47. Global Pain-relieving API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pain-relieving API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pain-relieving API Sales Value Share by Region (2021-2026) Table 50. Global Pain-relieving API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pain-relieving API Sales Value Share by Region (2027-2032) Table 52. Global Pain-relieving API Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Pain-relieving API Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Pain-relieving API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 57. Global Pain-relieving API Sales Market Share by Country (2021-2026) Table 58. Global Pain-relieving API Sales by Country (2027-2032) & (K Units) Table 59. Global Pain-relieving API Sales Market Share by Country (2027-2032) Table 60. Global Pain-relieving API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pain-relieving API Sales Value Market Share by Country (2021-2026) Table 62. Global Pain-relieving API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pain-relieving API Sales Value Market Share by Country (2027-2032) Table 64. Xinhua Pharmaceutical Company Information Table 65. Xinhua Pharmaceutical Business Overview Table 66. Xinhua Pharmaceutical Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Xinhua Pharmaceutical Pain-relieving API Product Portfolio Table 68. Xinhua Pharmaceutical Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sanofi Pain-relieving API Product Portfolio Table 73. Sanofi Recent Development Table 74. Biocause Heilen Company Information Table 75. Biocause Heilen Business Overview Table 76. Biocause Heilen Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biocause Heilen Pain-relieving API Product Portfolio Table 78. Biocause Heilen Recent Development Table 79. SOLARA Company Information Table 80. SOLARA Business Overview Table 81. SOLARA Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. SOLARA Pain-relieving API Product Portfolio Table 83. SOLARA Recent Development Table 84. SI Group Company Information Table 85. SI Group Business Overview Table 86. SI Group Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. SI Group Pain-relieving API Product Portfolio Table 88. SI Group Recent Development Table 89. Noramco Company Information Table 90. Noramco Business Overview Table 91. Noramco Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Noramco Pain-relieving API Product Portfolio Table 93. Noramco Recent Development Table 94. IOLCP Company Information Table 95. IOLCP Business Overview Table 96. IOLCP Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. IOLCP Pain-relieving API Product Portfolio Table 98. IOLCP Recent Development Table 99. Biocause Company Information Table 100. Biocause Business Overview Table 101. Biocause Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Biocause Pain-relieving API Product Portfolio Table 103. Biocause Recent Development Table 104. BASF Company Information Table 105. BASF Business Overview Table 106. BASF Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. BASF Pain-relieving API Product Portfolio Table 108. BASF Recent Development Table 109. Aspen API The Netherlands Company Information Table 110. Aspen API The Netherlands Business Overview Table 111. Aspen API The Netherlands Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Aspen API The Netherlands Pain-relieving API Product Portfolio Table 113. Aspen API The Netherlands Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Pain-relieving API Distributors List Table 117. Pain-relieving API Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Pain-relieving API Product Image Figure 2. Global Pain-relieving API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pain-relieving API Sales (2021-2032) & (K Units) Figure 5. Global Pain-relieving API Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pain-relieving API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Opiate Image Figure 10. Non-Opiate Image Figure 11. Global Pain-relieving API Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pain-relieving API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pain-relieving API Sales Volume Share by Type (2021-2032) Figure 14. Global Pain-relieving API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pain-relieving API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pain-relieving API Sales Value Share by Type (2021-2032) Figure 17. Contract Manufacturing Organizations Image Figure 18. Pharmaceutical Companies Image Figure 19. Others Image Figure 20. Global Pain-relieving API Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pain-relieving API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pain-relieving API Sales Volume Share by Application (2021-2032) Figure 23. Global Pain-relieving API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pain-relieving API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pain-relieving API Sales Value Share by Application (2021-2032) Figure 26. Global Pain-relieving API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Pain-relieving API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pain-relieving API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pain-relieving API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pain-relieving API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pain-relieving API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pain-relieving API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pain-relieving API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pain-relieving API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pain-relieving API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pain-relieving API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pain-relieving API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pain-relieving API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pain-relieving API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pain-relieving API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Opiate
  • Non-Opiate
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • Xinhua Pharmaceutical
  • Sanofi
  • Biocause Heilen
  • SOLARA
  • SI Group
  • Noramco
  • IOLCP
  • Biocause
  • BASF
  • Aspen API The Netherlands

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pain-relieving API Sales Value (2021-2032)
  4. 1.2.2 Global Pain-relieving API Sales Volume (2021-2032)
  5. 1.2.3 Global Pain-relieving API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pain-relieving API Market Dynamics
  1. 2.1 Pain-relieving API Industry Trends
  2. 2.2 Pain-relieving API Industry Drivers
  3. 2.3 Pain-relieving API Industry Opportunities and Challenges
  4. 2.4 Pain-relieving API Industry Restraints
3 Pain-relieving API Market by Company
  1. 3.1 Global Pain-relieving API Company Revenue Ranking in 2025
  2. 3.2 Global Pain-relieving API Revenue by Company (2021-2026)
  3. 3.3 Global Pain-relieving API Sales Volume by Company (2021-2026)
  4. 3.4 Global Pain-relieving API Average Price by Company (2021-2026)
  5. 3.5 Global Pain-relieving API Company Ranking (2024-2026)
  6. 3.6 Global Pain-relieving API Company Manufacturing Base and Headquarters
  7. 3.7 Global Pain-relieving API Company Product Type and Application
  8. 3.8 Global Pain-relieving API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pain-relieving API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pain-relieving API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pain-relieving API Market by Type
  1. 4.1 Pain-relieving API Type Introduction
  2. 4.1.1 Opiate
  3. 4.1.2 Non-Opiate
  4. 4.2 Global Pain-relieving API Sales Volume by Type
  5. 4.2.1 Global Pain-relieving API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pain-relieving API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pain-relieving API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pain-relieving API Sales Value by Type
  9. 4.3.1 Global Pain-relieving API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pain-relieving API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pain-relieving API Sales Value Share by Type (2021-2032)
5 Pain-relieving API Market by Application
  1. 5.1 Pain-relieving API Application Introduction
  2. 5.1.1 Contract Manufacturing Organizations
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Pain-relieving API Sales Volume by Application
  6. 5.2.1 Global Pain-relieving API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain-relieving API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pain-relieving API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pain-relieving API Sales Value by Application
  10. 5.3.1 Global Pain-relieving API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pain-relieving API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pain-relieving API Sales Value Share by Application (2021-2032)
6 Pain-relieving API Regional Sales and Value Analysis
  1. 6.1 Global Pain-relieving API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain-relieving API Sales by Region (2021-2032)
  3. 6.2.1 Global Pain-relieving API Sales by Region: 2021-2026
  4. 6.2.2 Global Pain-relieving API Sales by Region (2027-2032)
  5. 6.3 Global Pain-relieving API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pain-relieving API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pain-relieving API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pain-relieving API Sales Value by Region (2027-2032)
  9. 6.5 Global Pain-relieving API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pain-relieving API Sales Value (2021-2032)
  12. 6.6.2 North America Pain-relieving API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pain-relieving API Sales Value (2021-2032)
  15. 6.7.2 Europe Pain-relieving API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pain-relieving API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pain-relieving API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pain-relieving API Sales Value (2021-2032)
  21. 6.9.2 South America Pain-relieving API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pain-relieving API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pain-relieving API Sales Value Share by Country, 2025 VS 2032
7 Pain-relieving API Country-level Sales and Value Analysis
  1. 7.1 Global Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pain-relieving API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pain-relieving API Sales by Country (2021-2032)
  4. 7.3.1 Global Pain-relieving API Sales by Country (2021-2026)
  5. 7.3.2 Global Pain-relieving API Sales by Country (2027-2032)
  6. 7.4 Global Pain-relieving API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pain-relieving API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pain-relieving API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pain-relieving API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pain-relieving API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pain-relieving API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pain-relieving API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pain-relieving API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pain-relieving API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pain-relieving API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pain-relieving API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pain-relieving API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pain-relieving API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pain-relieving API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pain-relieving API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pain-relieving API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pain-relieving API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pain-relieving API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pain-relieving API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pain-relieving API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pain-relieving API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pain-relieving API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pain-relieving API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pain-relieving API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pain-relieving API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pain-relieving API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pain-relieving API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pain-relieving API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pain-relieving API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pain-relieving API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pain-relieving API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pain-relieving API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pain-relieving API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pain-relieving API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xinhua Pharmaceutical
  2. 8.1.1 Xinhua Pharmaceutical Company Information
  3. 8.1.2 Xinhua Pharmaceutical Business Overview
  4. 8.1.3 Xinhua Pharmaceutical Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xinhua Pharmaceutical Pain-relieving API Product Portfolio
  6. 8.1.5 Xinhua Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pain-relieving API Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Biocause Heilen
  14. 8.3.1 Biocause Heilen Company Information
  15. 8.3.2 Biocause Heilen Business Overview
  16. 8.3.3 Biocause Heilen Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biocause Heilen Pain-relieving API Product Portfolio
  18. 8.3.5 Biocause Heilen Recent Developments
  19. 8.4 SOLARA
  20. 8.4.1 SOLARA Company Information
  21. 8.4.2 SOLARA Business Overview
  22. 8.4.3 SOLARA Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SOLARA Pain-relieving API Product Portfolio
  24. 8.4.5 SOLARA Recent Developments
  25. 8.5 SI Group
  26. 8.5.1 SI Group Company Information
  27. 8.5.2 SI Group Business Overview
  28. 8.5.3 SI Group Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SI Group Pain-relieving API Product Portfolio
  30. 8.5.5 SI Group Recent Developments
  31. 8.6 Noramco
  32. 8.6.1 Noramco Company Information
  33. 8.6.2 Noramco Business Overview
  34. 8.6.3 Noramco Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Noramco Pain-relieving API Product Portfolio
  36. 8.6.5 Noramco Recent Developments
  37. 8.7 IOLCP
  38. 8.7.1 IOLCP Company Information
  39. 8.7.2 IOLCP Business Overview
  40. 8.7.3 IOLCP Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 IOLCP Pain-relieving API Product Portfolio
  42. 8.7.5 IOLCP Recent Developments
  43. 8.8 Biocause
  44. 8.8.1 Biocause Company Information
  45. 8.8.2 Biocause Business Overview
  46. 8.8.3 Biocause Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biocause Pain-relieving API Product Portfolio
  48. 8.8.5 Biocause Recent Developments
  49. 8.9 BASF
  50. 8.9.1 BASF Company Information
  51. 8.9.2 BASF Business Overview
  52. 8.9.3 BASF Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BASF Pain-relieving API Product Portfolio
  54. 8.9.5 BASF Recent Developments
  55. 8.10 Aspen API The Netherlands
  56. 8.10.1 Aspen API The Netherlands Company Information
  57. 8.10.2 Aspen API The Netherlands Business Overview
  58. 8.10.3 Aspen API The Netherlands Pain-relieving API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Aspen API The Netherlands Pain-relieving API Product Portfolio
  60. 8.10.5 Aspen API The Netherlands Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pain-relieving API Value Chain Analysis
  2. 9.1.1 Pain-relieving API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pain-relieving API Sales Mode & Process
  6. 9.2 Pain-relieving API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pain-relieving API Distributors
  9. 9.2.3 Pain-relieving API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst